As we navigate through 2026, the UK and Ireland healthcare landscape is undergoing its most profound transformation since the post-war era. Backed by the government’s 10-Year Health Plan and matching funding, the NHS is actively operationalising three critical shifts that have long dominated policy discussions:
The strategic narrative has firmly moved away from introducing "tech for tech’s sake" toward maximising frontline productivity. While the system remains under immense strain, former UK Health Secretary Wes Streeting recently noted that a "Herculean effort" has put the road to recovery clearly in sight—powered by a digitised world.
The numbers reflect this momentum:
At MEDITECH, we see firsthand how our Expanse platform plays a foundational role in helping our customers hit these targets. We have already delivered critical innovations to optimise waiting times functionality, with even deeper enhancements embedded in our future roadmap.
The NHS is currently executing the world’s largest healthcare deployment of generative AI, rolling out Microsoft 365 Copilot to 505,000 clinicians and support staff. On track for completion by October 2026, this rollout aims to eliminate the administrative burdens that heavily contribute to clinician burnout. Early data shows AI administrative support saves an average of 43 minutes per staff member, per day—returning two full days every month (or five weeks a year) back to frontline care.
MEDITECH is making excellent strides developing native solutions in this space. Our first tranche of generative AI features will soon be available to customers in a comprehensive bundle, focusing on:
These features are currently in general release across North American markets, and our regional teams are actively assessing the UK/I go-to-market strategy. Because governance and regulatory requirements differ across borders, these solutions will be introduced locally once approved by the appropriate regulatory authorities.
Further down the pipeline, ambient listening will be a cornerstone of our roadmap. We are supporting appropriately accredited third-party partners with seamless integration into Expanse, while simultaneously developing an in-house MEDITECH ambient solution for both NHS and private markets. Furthermore, testing is underway in the US for Agentic AI capabilities, including a "MEDITECH Helper" to provide data repository guidance and our emerging "Ask Expanse" chatbot.
The "Digitising the Frontline" milestone in March 2026—where 95% of trusts achieved baseline EPR maturity—is far more than a technical check-box; it is a clinical safety mandate. The transition toward a unified "Single Patient Record" is already delivering tangible benefits across our customer base:
By implementing "closed-loop technology" and scanning digital patient wristbands at the bedside, Alder Hey has achieved an incredible 50% reduction in medication errors. To build on this success, we are currently upgrading Alder Hey to our latest Expanse platform, giving them the modern foundation needed for enhanced workflows, advanced charting, and safer handovers.
Ranked first out of 134 acute trusts in England's NHS league tables, Moorfields holds an overall "Good" rating from the CQC, with an "Outstanding" score for effectiveness. Renowned for digital innovations like digital A&E consultations, the trust is currently implementing MEDITECH Expanse in preparation for "Oriel"—their new, world-leading smart hospital for eye care, research, and education. As part of their digital maturity, appointment letters are now sent digitally by default, resulting in faster communication, reduced administrative costs, and lower $CO_2e$ emissions.
Data from the Private Healthcare Information Network (PHIN) for March 2026 reveals an independent sector that is rapidly growing and shifting toward high-complexity specialisms. While overall private admissions rose by 1%, regional self-pay admissions surged by 10% in Scotland and Northern Ireland.
For the first time, chemotherapy has overtaken cataracts as the number one private procedure by volume (driven by the clinical reality of multiple cyclic admissions per patient). Concurrently, technology adoption mirrors the NHS, highlighted by a 29% increase in robotic-assisted hip replacements.
MEDITECH proudly supports some of the largest private hospital networks in the UK and Ireland. To ensure our private customers stay ahead of these shifting trends, we have dedicated clinical developments coming down the pipeline in Oncology, advanced billing workflows, and Genomics.
As the health service looks toward 2030, the defining question is no longer whether healthcare technology works, but how effectively, safely, and productively it can be sustained to permanently move users away from paper.
MEDITECH remains deeply committed to supporting the UK and Ireland through sustained, localised investment in our Expanse platform and regional teams. This strategy allows us to solve specific local market requirements while leveraging global advancements in health informatics.
Accelerating Timelines: We have recently concluded Phase 1 of our project to standardise our out-of-the-box offering. By providing a pre-configured suite of "Standard" workflows and functionalities, we are enabling our customers to bypass lengthy build times and accelerate their implementation timelines. Phase 2 of this initiative remains strictly on track for completion later this year.